Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock

Critical Care Medicine

Volumn 35, Issue 4, 2007, Pages 1019-1026

  McLean, Anthony S ^a   Huang, Stephen J ^a   Hyams, Stephanie ^a   Poh, Genie ^a   Nalos, Marek ^a   Pandit, Rahul ^a   Balik, Martin ^a,b   Tang, Ben ^a   Seppelt, Ian ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

B type natriuretic peptide; Cardiac dysfunction; Intensive care; Length of stay; Mortality; Severe sepsis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE CONTRACTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEPSIS; SEPTIC SHOCK;

EID: 34247151226     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000259469.24364.31     Document Type: Article

References (48)

1. Suttner SW, Boldt J: Natriuretic peptide system: Physiology and clinical utility. Curr Opin Crit Care 2004; 10:336-341
2. Maisel AS, McCord J, Nowak RM, et al: Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational study. J Am Coll Cardiol 2003; 41:2010-2017
3. McCullough PA, Novak RM, McCord J, et al: B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: Analysis form Breathing Not Properly Multinational study. Circulation 2002; 106:416-422
4. Doust JA, Pietrzak E, Dobson A, et al: How well does B-type natriuretic peptide predict death and cardiac events with heart failure? Systematic review. BMJ 2005; 330:625-633
5. Kalra PR, Anker SD, Coats AJS: Water and sodium regulation in chronic heart failure: The role of natriuretic peptides and vasopressin. Cardiovasc Res 2001; 51:495-509
6. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 1998; 339:321-328
7. Molkentin JD: A friend within the heart: Natriuretic peptide receptor signalling. J Clin Invest 2003; 111:1275-1277
8. Abraham WT, Lowes BD, Ferguson DA, et al: Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail 1998; 4:37-44
9. McLean AS, Tang B, Nalos M, et al: Increased B-type natriuretic peptide level is a strong predictor for cardiac dysfunction in intensive care unit patients. Anaesth Intensive Care 2003; 31:21-27
10. Cuthbertson BH, Patel RR, Croal BL, et al: B-type natriuretic peptide and the prediction of outcome in patients admitted to intensive care. Anaesthesia 2005; 60:16-21
11. Witthaut R, Busch C, Fraunberger P, et al: Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: Impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 2003; 29:1696-1702
12. McLean AS, Huang SJ, Nalos M, et al: The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients. Crit Care Med 2003; 31:2611-2618
13. Brun-Buisson C, Dyon F, Carlet J, et al: Incidence, risk factors and outcomes of severe sepsis and septic shock in adult. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. J Am Med Assoc 1995; 274:968-974
14. Pittet D, Rangel-Frausto S, Li N, et al: Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: Incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med 1995; 21:302-309
15. Salvo I, de Cian W, Musicco M, et al: The Italian SEPSIS study: Preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 1995; 21(Suppl 2):S244-S249
16. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
17. Finfer S, Bellomo R, Lipman J, et al: Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004; 30:589-596
18. Johnston JA: Determinants of mortality in patients with severe sepsis. Med Decision Making 2005; 25:374-386
19. Chien JY, Jerng JS, Yu CJ, et al: Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 2005; 33:1688-1693
20. Boots RJ, Lipman J, Bellomo R, et al: Disease risk and mortality prediction in intensive care patients with pneumonia. Australian and New Zealand practice in intensive care (ANZPIC II). Anaesth Intensive Care 2005; 33:101-111
21. Fernandes CJ, Akamine N, Knobel E: Cardiac troponin: A new serum marker of myocardial injury in sepsis. Intensive Care Med 1999; 25:1165-1168
22. Parker MM, Suffredini AF, Natanson C, et al: Responses of left ventricular function in survivors and nonsurvivors of septic shock. J Crit Care 1988; 4:19-25
23. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definition for sepsis and organ failure and guideline for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
24. Nagueh SF, Middleton KJ, Kopelen HA, et al: Doppler tissue imaging: A non-invasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30:1527-1533
25. Combes A, Arnoult F, Trouillet, J-L: Tissue Doppler imaging estimation of pulmonary artery occlusion pressure in ICU patients. Intensive Care Med 2004; 30:75-81
26. Yu CM, Lin H, Ho PC, et al: Assessment of left and right ventricular systolic and diastolic synchronicity in normal subjects by tissue Doppler echocardiography and the effects of age and heart rate. Echocardiography 2003; 20:19-27
27. Knaus WA, Draper EA, Wagner DP, et al: Apache II. A severity of disease classification system. Crit Care Med 1985; 13:818-829
28. Parker MM, Schelhamer JH, Bacharach SL, et al: Profound but reversible myocardial depression in patients with septic shock. An Intern Med 1984; 100:483-490
29. Jardin F, Fourme T, Page B, et al: Persistent preload defect in severe sepsis despite fluid loading. A longitudinal echocardiographic study in patients with septic shock. Chest 1999; 116:1354-1359
30. Schneider AJ, Teule GJ, Groeneveld BJ, et al: Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: A combined hemodynamic and radionuclide study. Am Heart J 1988; 116:103-112
31. Jardin F, Vltier B, Beauchet A, et al: Invasive monitoring combined with two-dimensional echocardiographic study in septic shock. Intensive Care Med 1994; 20:550-554
32. Charpentier J, Luyt C-E, Fulla Y, et al: Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004; 32:660-665
33. Rhodes A, Tilley R, Barnes S, et al: A prospective study into the use of NT-proBNP measurements in critically ill patients. Clin Intensive Care 2004; 25:31-36
34. Redington AN, Rigby ML, Shineborne EA, et al: Changes in the pressure-volume relation of the right ventricle when its loading conditions are modified. Br Heart J 1990; 63:45-49
35. Chin KM, Kim NHS, Rubum LJ: The right ventricle in pulmonary hypertension. Coron Artery Dis 2005; 16:13-18
36. Rudiger A, Gasser S, Fischler M, et al: Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med 2006; 34:2140-2144
37. McLean AS, Poh G, Huang SJ: Effects of acute fluid loading on plasma B-type natriuretic peptide levels in a septic shock patient. Anaesth Intensive Care 2005; 33:528-530
38. Ishii J, Nomura M, Ito M, et al: Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease. Clin Chim Acta 2000; 301:19-30
39. Tanaka T, Kanda T, Takajashi T, et al: Interleukin-6 induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes. J Int Med Res 2004; 32:57-61
40. Wallen T, Landahl S, Hedner T, et al: Brain natriuretic peptide predicts mortality in the elderly. Heart 1997; 77:264-267
41. Wang TJ, Larson MG, Levy D, et al: Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350:655-663
42. Cuthbertson BH, McKeown A, Croal BL, et al: Utility of B-type natriuretic peptide in predicting the level of peri and postoperative cardiovascular support required after coronary artery bypass surgery. Crit Care Med 2005; 33:437-442
43. Tung RH, Garcia C, Morss AM, et al: Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 2004; 32:1643-1647
44. Provenchere S, Berroeta C, Reynaud C, et al: Plasma brain natriuretic peptide and cardiac troponin I concentrations after cardiac surgery: Association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med 2006; 34:995-1000
45. Roch A, Allardet-Servent J, Michelet P, et al: NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med 2005; 33:1001-1007
46. Skerrett SJ, Niederman MS, Fein AM: Respiratory infections and acute lung injury in systemic illness. Clin Chest Med 1989; 10:469-502
47. Pinsky, MR: Clinical significance of pulmonary artery occlusion pressure. Intensive Care Med 2003; 29:175-178
48. LeDoux D, Astiz ME, Carpati CM, et al: Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000; 28:2729-2732